Tenax Therapeutics Inc Sustainability Reports
Tenax Therapeutics, Inc. is a pharmaceutical company focused on identifying and developing therapeutics for cardiovascular and pulmonary diseases. The company is actively advancing clinical trials for levosimendan to treat heart failure with preserved ejection fraction and related pulmonary hypertension.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300J03O6B1IJ2B606
FIGI: BBG001S78GM3
8 reports from 2015 to 2024